Funded Tech Companies

Heptares Therapeutics

Headquartered in Welwyn Garden City Hertfordshire, Heptares Therapeutics was bought by Sosei Group.

Company Overview

Company Name
Heptares Therapeutics
Company Status
Acquired or Merged

Contact Information

Mailing Address
Bio Park Broadwater Road
Welwyn Garden City Hertfordshire, AL7 3AX
UK
Email Address

Company Background Information

Overview
Heptares creates new medicines targeting previously undruggable or challenging GPCRs, a superfamily of receptors linked to many diseases. We are pioneering a structure-based drug design approach to GPCRs, leveraging proprietary technologies for protein stabilisation, structure determination, and fragment-based discovery.
Profile
Heptares Therapeutics LinkedIn Company Profile
Social Media
Heptares Therapeutics Company Twitter Account
Company News
Heptares Therapeutics News
Facebook
Heptares Therapeutics on Facebook
YouTube
Heptares Therapeutics on YouTube
Last Transaction
2/23/2015

Financing History

Date
Type
Amount
M&A
$400,000,000
Venture Equity
$21,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Malcolm Weir
  Malcolm Weir LinkedIn Profile  Malcolm Weir Twitter Account  Malcolm Weir News  Malcolm Weir on Facebook
Chief Medical Officer
Tim Tasker
  Tim Tasker LinkedIn Profile  Tim Tasker Twitter Account  Tim Tasker News  Tim Tasker on Facebook
Chief Scientific Officer
Fiona Marshall
  Fiona Marshall LinkedIn Profile  Fiona Marshall Twitter Account  Fiona Marshall News  Fiona Marshall on Facebook
President
Daniel Grau
  Daniel Grau LinkedIn Profile  Daniel Grau Twitter Account  Daniel Grau News  Daniel Grau on Facebook


Company Investors

  • Takeda Ventures
  • Clarus
  • Stanley Family Foundation

 

 

 

Browse more funded tech companies:

hepster | Heptio

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary